This Giving Tuesday, help us change what it means to be diagnosed with lung cancer.

Your support today directly powers lung cancer science and brings us closer to making lung cancer a survivable disease. #lungcancer

Donate today! alcmi.org/join-us/dona...

To every patient who has enrolled in an ALCMI clinical trial—who has said yes to advancing science even as they face their own uncertain journey—we are profoundly grateful. #lungcancer #thankyou

Please consider referring your small cell lung cancer patients to the SUCCEED Study. Now enrolling! #lungcancer #sclc #clinicaltrials alcmi.org/succeed

On this day of reflection, we honor every person who has faced lung cancer, the physicians who help them fight, the advocates working to raise awareness, and the researchers who are leading us toward a brighter future.
#worldlungcancerday #lungcancer

The SUCCEED Study, led by Dr. Christine Lovly, is now enrolling patients. Learn more at alcmi.org/clinical-tri...
#lungcancer #sclc

Calling all lung cancer physicians and researchers! If you’re caring for patients with small cell lung cancer, we invite you to refer eligible individuals to the SUCCEED Study, a prospective observational study now enrolling people across the U.S. #lungcancer #sclc

Happy 4th of July from all of us at ALCMI! As we celebrate independence and community, we're grateful for the dedication and hard work that drives progress in our field. Wishing everyone a safe and joyful holiday. #lungcancer

At ALCMI, we're dedicated to advancing lung cancer research and improving patient outcomes. Today, we're thrilled to announce that we're preparing to make a significant commitment to small cell lung cancer (SCLC) research. #lungcancer #sclc

We're currently enrolling people in our ENIGMA study, and we can use your help. Our study, developed with Massachusetts General Hospital and GO2 for Lung Cancer, aims to understand why tumor resistance develops with ALK+ targeted therapy. Learn more here buff.ly/43cx3rM

We're here exhibiting at Targeted Therapies for Lung Cancer in Huntington Beach, CA, and ready to talk about your next research project! Stop by to see how we can help with funding, staffing, and support! #lungcancer #ttlc25

Starting today, this week, we're at the 2025 Targeted Therapies of Lung Cancer Meeting! We're exhibiting at Table #8. If you're here in Huntington Beach, stop by to say hi! We'd love to introduce ourselves and tell you how we accelerate investigator-initiated clinical trials. #lungcancer #TTLC25

Are you going to the IASLC 2025 Targeted Therapies of Lung Cancer in Huntington Beach, CA? We'll be there and would love to connect. Stop by to say hi! #lungcancer

Pioneering research led by Dr. Antonious Hazim, Dr. Konstantinos Leventakos, and Dr. Vinicius Ernani, and published in JCO Oncology Practice, explores the transformative potential of immunomodulatory agents in tackling small cell lung cancer. #lungcancer
https://buff.ly/4gshFuw

Are you a lung cancer researcher? Do have an idea for a clinical trial? If so, we should talk. We accelerate investigator-initiated clinical trials by providing funding, support, specimen collection, and more. Visit us at alcmi.org. #lungcancer

Big strides are being made in the battle against small cell lung cancer (SCLC). A recent review published in the journal Cancers highlights a promising new wave of therapies targeting specific molecular pathways. #lungcancer
https://buff.ly/3WGTZvq

On this World Cancer Day, we honor the patients, families, physicians, and researchers who have confronted this disease. We look forward to a healthier, happier, cancer-free future. #worldcancerday #lungcancer